These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 32628593)

  • 1. Nitrogen-Containing Heterocycles as Anticancer Agents: An Overview.
    Lang DK; Kaur R; Arora R; Saini B; Arora S
    Anticancer Agents Med Chem; 2020; 20(18):2150-2168. PubMed ID: 32628593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship (SAR) study and design strategies of nitrogen-containing heterocyclic moieties for their anticancer activities.
    Akhtar J; Khan AA; Ali Z; Haider R; Shahar Yar M
    Eur J Med Chem; 2017 Jan; 125():143-189. PubMed ID: 27662031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxygen- and Sulphur-Containing Heterocyclic Compounds as Potential Anticancer Agents.
    Sachdeva H; Khaturia S; Saquib M; Khatik N; Khandelwal AR; Meena R; Sharma K
    Appl Biochem Biotechnol; 2022 Dec; 194(12):6438-6467. PubMed ID: 35900713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrogen Containing Heterocycles as Anticancer Agents: A Medicinal Chemistry Perspective.
    Kumar A; Singh AK; Singh H; Vijayan V; Kumar D; Naik J; Thareja S; Yadav JP; Pathak P; Grishina M; Verma A; Khalilullah H; Jaremko M; Emwas AH; Kumar P
    Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Medicinal Chemist's Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents.
    Nehra B; Mathew B; Chawla PA
    Curr Top Med Chem; 2022; 22(6):493-528. PubMed ID: 35021975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1,3,4-Oxadiazole: An Emerging Scaffold to Inhibit the Thymidine Phosphorylase as an Anticancer Agent.
    Murmu A; Banjare P; Matore BW; Roy PP; Singh J
    Curr Med Chem; 2024; 31(38):6227-6250. PubMed ID: 37438902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrogen-fused Heterocycles: Empowering Anticancer Drug Discovery.
    Biswas T; Mittal RK; Sharma V; Kanupriya ; Mishra I
    Med Chem; 2024; 20(4):369-384. PubMed ID: 38192143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentacyclic Triterpenoids with Nitrogen-Containing Heterocyclic Moiety, Privileged Hybrids in Anticancer Drug Discovery.
    Khwaza V; Mlala S; Oyedeji OO; Aderibigbe BA
    Molecules; 2021 Apr; 26(9):. PubMed ID: 33918996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comprehensive Review of N-Heterocycles as Cytotoxic Agents.
    Kumar D; Jain SK
    Curr Med Chem; 2016; 23(38):4338-4394. PubMed ID: 27516198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applications of Pyrrole and Pyridine-based Heterocycles in Cancer Diagnosis and Treatment.
    Tyagi R; Yadav K; Srivastava N; Sagar R
    Curr Pharm Des; 2024; 30(4):255-277. PubMed ID: 38711394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Review on the Antitumor Activity of Various Nitrogenous-based Heterocyclic Compounds as NSCLC Inhibitors.
    Liu JC; Narva S; Zhou K; Zhang W
    Mini Rev Med Chem; 2019; 19(18):1517-1530. PubMed ID: 30864519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: an update of recent developments.
    Steeghs N; Nortier JW; Gelderblom H
    Ann Surg Oncol; 2007 Feb; 14(2):942-53. PubMed ID: 17103252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Potential of N-heterocyclic Analogs as Anti-inflammatory Agents.
    Dhingra AK; Chopra B; Dua JS; Prasad DN
    Antiinflamm Antiallergy Agents Med Chem; 2017; 16(3):136-152. PubMed ID: 29376495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erlotinib: CP 358774, NSC 718781, OSI 774, R 1415.
    Adis International Ltd
    Drugs R D; 2003; 4(4):243-8. PubMed ID: 12848590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advances in Nitrogen-Containing Heterocyclic Scaffolds as Antiviral Agents.
    Kanupriya ; Mittal RK; Sharma V; Biswas T; Mishra I
    Med Chem; 2024; 20(5):487-502. PubMed ID: 38279757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Recent Advances in Nitrogen-Containing Molecules and Their Biological Applications.
    Kerru N; Gummidi L; Maddila S; Gangu KK; Jonnalagadda SB
    Molecules; 2020 Apr; 25(8):. PubMed ID: 32326131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-cancer pyrimidines in diverse scaffolds: a review of patent literature.
    Kaur R; Kaur P; Sharma S; Singh G; Mehndiratta S; Bedi PM; Nepali K
    Recent Pat Anticancer Drug Discov; 2015; 10(1):23-71. PubMed ID: 25230072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Six-Membered Aromatic Nitrogen Heterocyclic Anti-Tumor Agents: Synthesis and Applications.
    Li J; Gu A; Nong XM; Zhai S; Yue ZY; Li MY; Liu Y
    Chem Rec; 2023 Dec; 23(12):e202300293. PubMed ID: 38010365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013-2023).
    Marshall CM; Federice JG; Bell CN; Cox PB; Njardarson JT
    J Med Chem; 2024 Jul; 67(14):11622-11655. PubMed ID: 38995264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling dynamics of nitrogen content and selected nitrogen heterocycles in thrombin inhibitors: a
    Masand VH; Al-Hussain S; Alzahrani AY; Al-Mutairi AA; Sultan Alqahtani A; Samad A; Alafeefy AM; Jawarkar RD; Zaki MEA
    Expert Opin Drug Discov; 2024 Aug; 19(8):991-1009. PubMed ID: 38898679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.